I think, ultimately, the big issue for many will be what happens in the United States if we hear about people who didn't go to China who have come down with the disease.
ABBV could bounce today but there remains the risk of a deeper correction.
The biopharma giant could fall further, so wait for a candlestick reversal pattern before going long.
Many market players - including me - would be relieved to see a decent bout of selling.
American Airlines, Supernus Pharmaceuticals and TPI Composites should see their fortunes improve this year.
Barring a negative surprise I would look for higher highs to be established in the days and weeks ahead.
Our latest analysis and trading strategy for the the big pharma stock.
The clinical stage company sees its shares climb after announcing some significant news during this week's J.P. Morgan Healthcare Conference.
Here's how two big events early this week make me view this name that's one of my favorite undervalued, dividend-paying companies.
Let's review the charts.